IgA vasculitis update: epidemiology, pathogenesis, and biomarkers

L Xu, Y Li, X Wu - Frontiers in Immunology, 2022 - frontiersin.org
Immunoglobulin A vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the
most common systemic vasculitis in children, characterized by diverse clinical …

IgA vasculitis: etiology, treatment, biomarkers and epigenetic changes

H Sugino, Y Sawada, M Nakamura - International journal of molecular …, 2021 - mdpi.com
IgA, previously called Henoch-Schönlein vasculitis, is an essential immune component that
drives the host immune response to the external environment. As IgA has the unique …

The neutrophil: A key resourceful agent in immune‐mediated vasculitis

K Aymonnier, J Amsler, P Lamprecht… - Immunological …, 2023 - Wiley Online Library
The term “vasculitis” refers to a group of rare immune‐mediated diseases characterized by
the dysregulated immune system attacking blood vessels located in any organ of the body …

[HTML][HTML] Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review

R López-Mejías, S Castañeda, F Genre… - Autoimmunity …, 2018 - Elsevier
Immunoglobulin-A vasculitis (IgAV) is classically a childhood small-sized blood vessel
vasculitis with predominant involvement of the skin. Gastrointestinal and joint manifestations …

IgA vasculitis with nephritis: update of pathogenesis with clinical implications

MC Hastings, DV Rizk, K Kiryluk, R Nelson, RS Zahr… - Pediatric …, 2022 - Springer
IgA vasculitis with nephritis (IgAVN) shares many pathogenetic features with IgA
nephropathy (IgAN). The purpose of this review is to describe our current understanding of …

New insights and challenges associated with IgA vasculitis and IgA vasculitis with nephritis—is it time to change the paradigm of the most common systemic vasculitis …

M Jelusic, M Sestan, T Giani, R Cimaz - Frontiers in pediatrics, 2022 - frontiersin.org
What are the challenges ahead and how have we responded so far when it comes to the
non-granulomatous systemic vasculitis, characterized mainly by deposits of IgA immune …

Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein)

F Maritati, R Fenoglio, E Pillebout, G Emmi… - Arthritis & …, 2018 - Wiley Online Library
Objective Adult‐onset IgA vasculitis (Henoch‐Schönlein)(Ig AV) is a rare systemic vasculitis
characterized by IgA1‐dominant deposits. The treatment of adult‐onset Ig AV is …

IgA vasculitis: genetics and clinical and therapeutic management

MA González-Gay, R López-Mejías, T Pina… - Current Rheumatology …, 2018 - Springer
Abstract Purpose of Review The purpose of the study is to perform an update on the current
knowledge on genetics, clinical manifestations, and therapy in immunoglobulin A vasculitis …

Genome-wide associations reveal human-mouse genetic convergence and modifiers of myogenesis, CPNE1 and STC2

AIH Cordero, NM Gonzales, CC Parker… - The American Journal of …, 2019 - cell.com
Muscle bulk in adult healthy humans is highly variable even after height, age, and sex are
accounted for. Low muscle mass, due to fewer and/or smaller constituent muscle fibers …

Comparing immunoglobulin A vasculitis (Henoch–Schönlein purpura) in children and adults: a single-centre study from Turkey

ED Batu, A Sarı, A Erden, HE Sönmez… - Scandinavian Journal …, 2018 - Taylor & Francis
Objective: Immunoglobulin A vasculitis/Henoch–Schönlein purpura (IgAV/HSP) is a systemic
vasculitis involving small vessels with the deposition of immune complexes containing IgA. It …